🇺🇸 FDA
Pipeline program

Atorvastatin

2006BAI01A02-03

Unknown small_molecule active

Quick answer

Atorvastatin for Atherosclerosis is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Atherosclerosis
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials